Ligand supplementation restores the cancer therapy efficacy of the antirheumatic drug auranofin from serum inactivation

Y Yuan Wang B Bei Cao (College of Education Sciences) Q Qianqian Wang (Department of Materials Science and Engineering) S Sinan Zhong X Xin Fang J Junjian Wang (Guangdong Provincial Key Laboratory of New Drug Design and Evaluation, School of Pharmaceutical Sciences, Sun Yat-sen University) A Albert S. C. Chan X Xiaolin Xiong (State Key Laboratory of Anti-Infective Drug Discovery and Development, Guangdong Key Laboratory of Chiral Molecule and Drug Discovery, and School of Pharmaceutical Sciences) T Taotao Zou (State Key Laboratory of Anti-Infective Drug Discovery and Development, Guangdong Key Laboratory of Chiral Molecule and Drug Discovery, and School of Pharmaceutical Sciences)

Article Details

Volume / Issue Vol. 16, Issue 1
Published August 09, 2025
ISSN 2041-1723
Publisher Nature Portfolio

Journal Info

Nature Communications

Nature Portfolio

ISSN: 2041-1723 Open Access Life Sciences

Authors (9)

Y

Yuan Wang

B

Bei Cao

College of Education Sciences

Q

Qianqian Wang

Department of Materials Science and Engineering

S

Sinan Zhong

X

Xin Fang

J

Junjian Wang

Guangdong Provincial Key Laboratory of New Drug Design and Evaluation, School of Pharmaceutical Sciences, Sun Yat-sen University

A

Albert S. C. Chan

X

Xiaolin Xiong

State Key Laboratory of Anti-Infective Drug Discovery and Development, Guangdong Key Laboratory of Chiral Molecule and Drug Discovery, and School of Pharmaceutical Sciences

T

Taotao Zou

State Key Laboratory of Anti-Infective Drug Discovery and Development, Guangdong Key Laboratory of Chiral Molecule and Drug Discovery, and School of Pharmaceutical Sciences